Search Within

Maria Michelle Rubinstein

Formats
  1. Journal Article (22)
  2. Meeting Abstract (13)
  3. Review (4)
Groups
  1. GDMT, Medicine (39)
  2. Gynecologic Medicine Service (39)
  3. Gynecology Disease Management Team (39)
  4. Solid Tumor Oncology Division (39)
  5. Weinberg Fellows (39)
  6. Department of Medicine (33)

More Groups

People
  1. Vicky Makker (28)
  2. Carol Aghajanian (21)
  3. Alexia Iasonos (15)
  4. Rachel Grisham (15)
  5. Britta Weigelt (13)
  6. Claire Friedman (13)

More People

Years
  1. 2025 (6)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Gynecologic Oncology (13)
  2. International Journal of Gynecological Cancer (5)
  3. Journal of Clinical Oncology (5)
  4. Gynecologic Oncology Reports (3)
  5. Clinical Cancer Research (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (14)
  2. Lippincott Williams & Wilkins (7)
  3. American Society of Clinical Oncology (5)
  4. American Association for Cancer Research (3)
  5. Elsevier B.V. (3)
  6. Nature Publishing Group (2)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: Strategies for prevention and treatment
    Review

    Lightfoot, M. D. S.; Rubinstein, M. M.; Monk, B. J.; Eskander, R. N.; Lutz, K.; Moore, K. N.; Herzog, T. J.; Pothuri, B.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Novel androgen receptor splice variant 7 in gynecologic tumors
    Journal Article

    Wang, L.; Vasudevaraja, V.; Tran, I.; Sukhadia, P.; Reuter, V. E.; Abu-Rustum, N. R.; Rubinstein, M. M.; Gopalan, A.; Ross, D.; Snuderl, M.; more...
    International Journal of Gynecological Pathology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Mismatch repair deficiency and tumor mutational burden are associated with higher microbiome diversity in the reproductive tract
    Meeting Abstract

    Rubinstein, M.; Gradissimo, A.; Taur, Y.; Varice, N.; Roche, K. L.; Broach, V.; Leitao, M.; Sonoda, Y.; Weigelt, B.; Zivanovic, O.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save